Multiplexed multicolor antiviral assay amenable for high-throughput research
Li-Hsin Li,Winston Chiu,Yun-An Huang,Madina Rasulova,Thomas Vercruysse,Hendrik Jan Thibaut,Sebastiaan ter Horst,Joana Rocha-Pereira,Greet Vanhoof,Doortje Borrenberghs,Olivia Goethals,Suzanne J. F. Kaptein,Pieter Leyssen,Johan Neyts,Kai Dallmeier
DOI: https://doi.org/10.1038/s41467-023-44339-z
IF: 16.6
2024-01-02
Nature Communications
Abstract:Abstract To curb viral epidemics and pandemics, antiviral drugs are needed with activity against entire genera or families of viruses. Here, we develop a cell-based multiplex antiviral assay for high-throughput screening against multiple viruses at once, as demonstrated by using three distantly related orthoflaviviruses: dengue, Japanese encephalitis and yellow fever virus. Each virus is tagged with a distinct fluorescent protein, enabling individual monitoring in cell culture through high-content imaging. Specific antisera and small-molecule inhibitors are employed to validate that multiplexing approach yields comparable inhibition profiles to single-virus infection assays. To facilitate downstream analysis, a kernel is developed to deconvolute and reduce the multidimensional quantitative data to three cartesian coordinates. The methodology is applicable to viruses from different families as exemplified by co-infections with chikungunya, parainfluenza and Bunyamwera viruses. The multiplex approach is expected to facilitate the discovery of broader-spectrum antivirals, as shown in a pilot screen of approximately 1200 drug-like small-molecules.
multidisciplinary sciences